Protopanaxatriol

CAS No. 1453-93-6

Protopanaxatriol( 20(R)-APPT )

Catalog No. M18030 CAS No. 1453-93-6

Protopanaxatriol, a major ginseng constituent, is a novel PPARγ antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 80 In Stock
5MG 64 In Stock
10MG 104 In Stock
25MG 187 In Stock
50MG 300 In Stock
100MG 449 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Protopanaxatriol
  • Note
    Research use only, not for human use.
  • Brief Description
    Protopanaxatriol, a major ginseng constituent, is a novel PPARγ antagonist.
  • Description
    Protopanaxatriol, a major ginseng constituent, is a novel PPARγ antagonist.
  • In Vitro
    20(R)-Protopanaxatriol is a natural aglycone of ginsenosides Re, Rf, Rg1, Rg2 and Rh.
  • In Vivo
    ——
  • Synonyms
    20(R)-APPT
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PPARγ
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1453-93-6
  • Formula Weight
    476.73
  • Molecular Formula
    C30H32O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 32 mg/mL; 67.12 mM
  • SMILES
    C1C[C@@H](C([C@@H]2[C@H](C[C@]3([C@@]4(CC[C@@H]([C@H]4[C@@H](C[C@@H]3[C@@]12C)O)[C@@](C)(CCC=C(C)C)O)C)C)O)(C)C)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhang Y, et al. Protopanaxatriol, a novel PPARγ antagonist from Panax ginseng, alleviates steatosis in mice. Sci Rep. 2014 Dec 9;4:7375.
molnova catalog
related products
  • PKUMDL-WQ-2101

    PKUMDL-WQ-2101 is a selective allosteric inhibitor of phosphoglycerate dehydrogenase (PHGDH) with anti-tumor activity, it binds to site I.

  • Pimonidazole hydroch...

    Pimonidazole hydrochloride accumulates in hypoxic cells via covalent binding with macromolecules or by forming reductive metabolites after the reduction of its nitro group.

  • Lesinurad

    Lesinurad is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout.